Private Wealth Partners LLC lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 59.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513 shares of the semiconductor company's stock after selling 745 shares during the quarter. Private Wealth Partners LLC's holdings in Synopsys were worth $220,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in SNPS. Ameriflex Group Inc. bought a new stake in shares of Synopsys during the 4th quarter valued at $29,000. Whipplewood Advisors LLC acquired a new position in Synopsys in the fourth quarter valued at about $33,000. Pilgrim Partners Asia Pte Ltd bought a new stake in Synopsys during the fourth quarter worth about $34,000. Hazlett Burt & Watson Inc. grew its stake in Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after buying an additional 20 shares in the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC grew its stake in Synopsys by 50.8% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company's stock worth $48,000 after buying an additional 33 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $457.93, for a total value of $5,204,832.38. Following the transaction, the chief executive officer now directly owns 71,589 shares in the company, valued at approximately $32,782,750.77. This represents a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shelagh Glaser sold 7,310 shares of Synopsys stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the sale, the chief financial officer now owns 15,291 shares of the company's stock, valued at approximately $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by insiders.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $473.62 on Friday. The firm has a market capitalization of $73.49 billion, a PE ratio of 34.20, a P/E/G ratio of 3.13 and a beta of 1.11. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. The company has a 50-day moving average price of $471.43 and a two-hundred day moving average price of $479.64. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $624.80.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same period last year, the firm earned $3.00 EPS. Synopsys's revenue for the quarter was up 10.3% on a year-over-year basis. Equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on SNPS. Bank of America reduced their target price on Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a report on Wednesday, April 16th. Rosenblatt Securities dropped their price target on shares of Synopsys from $660.00 to $625.00 and set a "buy" rating on the stock in a research report on Thursday, May 29th. Wells Fargo & Company decreased their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. KeyCorp set a $540.00 price target on Synopsys in a research note on Tuesday, June 3rd. Finally, Needham & Company LLC restated a "buy" rating and issued a $650.00 price target on shares of Synopsys in a report on Thursday, May 29th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to MarketBeat, Synopsys currently has an average rating of "Moderate Buy" and an average price target of $607.14.
Check Out Our Latest Report on Synopsys
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.